Sharon E. Parker
Impact in
-
- Antibiotic Use and Resistance
- Pharmacology top 10%
- Antibiotics Pharmacokinetics and Efficacy
Papers in
-
- Antibiotic Use and Resistance 7
-
- Antibiotics Pharmacokinetics and Efficacy 4
- Co-authors
- Peter Davey (10 shared papers)Gary D. Kao (3 shared papers)Geoffrey A. Geiger (1 shared paper)Mary C. Mullins (1 shared paper)Jennifer Tucker (1 shared paper)Melissa L. Dowling (2 shared papers)Mijin Kim (1 shared paper)Fang Liu (1 shared paper)
- Journals
- PharmacoEconomics (4 papers)Journal of Antimicrobial Chemotherapy (4 papers)Cancer Research (2 papers)European Psychiatry (1 paper)The Journal of Clinical Pharmacology (1 paper)
- Partner nations
- United KingdomUnited StatesAustralia
In The Last Decade
Sharon E. Parker
17 papers receiving 441 citations
Peers
Comparison fields: 5 of 93
- Applied Microbiology and Biotechnology 73
- Pharmacology 112
- Molecular Medicine 32
- Cell Biology 76
- Clinical Biochemistry 21
Countries citing papers authored by Sharon E. Parker
This map shows the geographic impact of Sharon E. Parker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sharon E. Parker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sharon E. Parker more than expected).
Fields of papers citing papers by Sharon E. Parker
This network shows the impact of papers produced by Sharon E. Parker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sharon E. Parker. The network helps show where Sharon E. Parker may publish in the future.
Co-authors
The 25 scholars most cited alongside Sharon E. Parker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 90 | |
| 2 | 1992 | 69 | |
| 3 | 2005 | 53 | |
| 4 | 1993 | 45 | |
| 5 | 1992 | 42 | |
| 6 | 2008 | 38 | |
| 7 | 1998 | 26 | |
| 8 | 1992 | 25 | |
| 9 | 1995 | 15 | |
| 10 | 1995 | 14 | |
| 11 | Assessing cost effectiveness of antimicrobial treatment: monotherapy compared with combination therapy. | 1994 | 14 |
| 12 | 1995 | 12 | |
| 13 | 2019 | 11 | |
| 14 | 1993 | 7 | |
| 15 | National Appraisal of Continuous Quality Improvement Initiatives in Aboriginal and Torres Strait Islander Primary Health Care : Final report March 2013 | 2013 | 6 |
| 16 | Multidisciplinary team briefings: A way forward | 2015 | 4 |
| 17 | 2015 | 1 |
About Sharon E. Parker
Sharon E. Parker is a scholar working on Applied Microbiology and Biotechnology, Pharmacology, Pediatrics, Perinatology and Child Health, Economics and Econometrics and Molecular Biology, having authored 17 papers that have together received 472 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (7 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmaceutical studies and practices (4 papers), Microtubule and mitosis dynamics (2 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers), DNA Repair Mechanisms (1 paper), Cardiac, Anesthesia and Surgical Outcomes (1 paper) and Nausea and vomiting management (1 paper). The work is most often cited by research in Applied Microbiology and Biotechnology (73 citations), Pharmacology (112 citations), Molecular Medicine (32 citations), Cell Biology (76 citations) and Clinical Biochemistry (21 citations). Sharon E. Parker has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Peter Davey, Gary D. Kao, Geoffrey A. Geiger, Mary C. Mullins, Jennifer Tucker, Melissa L. Dowling, Mijin Kim, Fang Liu, Mijin Kim and Dilip Nathwani. Their work appears in journals such as PharmacoEconomics, Journal of Antimicrobial Chemotherapy, Cancer Research, European Psychiatry and The Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.